Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34004102235;102236;102237 chr2:178534605;178534604;178534603chr2:179399332;179399331;179399330
N2AB3236397312;97313;97314 chr2:178534605;178534604;178534603chr2:179399332;179399331;179399330
N2A3143694531;94532;94533 chr2:178534605;178534604;178534603chr2:179399332;179399331;179399330
N2B2493975040;75041;75042 chr2:178534605;178534604;178534603chr2:179399332;179399331;179399330
Novex-12506475415;75416;75417 chr2:178534605;178534604;178534603chr2:179399332;179399331;179399330
Novex-22513175616;75617;75618 chr2:178534605;178534604;178534603chr2:179399332;179399331;179399330
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Kinase-1
  • Domain position: 192
  • Q(SASA): 0.0889
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/P None None None D None 0.732 0.869283475951 gnomAD-4.0.0 1.36845E-06 None None None None N None 0 0 None 0 0 None 0 0 1.79902E-06 0 0
L/Q rs727504897 -2.878 None D None 0.652 0.881451469118 gnomAD-2.1.1 8.04E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.78E-05 0
L/Q rs727504897 -2.878 None D None 0.652 0.881451469118 gnomAD-4.0.0 1.36845E-05 None None None None N None 0 0 None 0 0 None 0 0 1.70907E-05 0 1.65651E-05
L/V None None None N None 0.226 0.473538153929 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 0 0 3.66327E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8122 likely_pathogenic 0.7958 pathogenic -2.553 Highly Destabilizing None None None None None None None None N
L/C 0.9445 likely_pathogenic 0.9382 pathogenic -1.855 Destabilizing None None None None None None None None N
L/D 0.9972 likely_pathogenic 0.9968 pathogenic -3.312 Highly Destabilizing None None None None None None None None N
L/E 0.9833 likely_pathogenic 0.9819 pathogenic -2.98 Highly Destabilizing None None None None None None None None N
L/F 0.6522 likely_pathogenic 0.5963 pathogenic -1.588 Destabilizing None None None None None None None None N
L/G 0.9792 likely_pathogenic 0.9797 pathogenic -3.185 Highly Destabilizing None None None None None None None None N
L/H 0.9751 likely_pathogenic 0.9736 pathogenic -3.048 Highly Destabilizing None None None None None None None None N
L/I 0.259 likely_benign 0.2357 benign -0.662 Destabilizing None None None None None None None None N
L/K 0.9781 likely_pathogenic 0.9766 pathogenic -2.119 Highly Destabilizing None None None None None None None None N
L/M 0.3226 likely_benign 0.3087 benign -0.742 Destabilizing None None None None N 0.515761863 None None N
L/N 0.9822 likely_pathogenic 0.9815 pathogenic -2.861 Highly Destabilizing None None None None None None None None N
L/P 0.9938 likely_pathogenic 0.9937 pathogenic -1.282 Destabilizing None None None None D 0.53103278 None None N
L/Q 0.9568 likely_pathogenic 0.9563 pathogenic -2.457 Highly Destabilizing None None None None D 0.530779291 None None N
L/R 0.971 likely_pathogenic 0.9703 pathogenic -2.261 Highly Destabilizing None None None None D 0.530779291 None None N
L/S 0.9538 likely_pathogenic 0.9529 pathogenic -3.431 Highly Destabilizing None None None None None None None None N
L/T 0.8132 likely_pathogenic 0.8056 pathogenic -2.921 Highly Destabilizing None None None None None None None None N
L/V 0.3194 likely_benign 0.3027 benign -1.282 Destabilizing None None None None N 0.455438549 None None N
L/W 0.954 likely_pathogenic 0.9445 pathogenic -2.064 Highly Destabilizing None None None None None None None None N
L/Y 0.9649 likely_pathogenic 0.9579 pathogenic -1.776 Destabilizing None None None None None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.